Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 2
1995 1
1996 6
1997 2
1998 2
1999 3
2000 4
2001 3
2002 6
2003 4
2004 7
2005 3
2006 4
2007 3
2008 7
2009 10
2010 8
2011 6
2012 5
2013 9
2014 8
2015 9
2016 10
2017 9
2018 5
2019 2
2020 3
2021 6
2022 3
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

136 results
Results by year
Filters applied: . Clear all
Page 1
Riociguat for the treatment of chronic thromboembolic pulmonary hypertension.
Ghofrani HA, D'Armini AM, Grimminger F, Hoeper MM, Jansa P, Kim NH, Mayer E, Simonneau G, Wilkins MR, Fritsch A, Neuser D, Weimann G, Wang C; CHEST-1 Study Group. Ghofrani HA, et al. Among authors: d armini am. N Engl J Med. 2013 Jul 25;369(4):319-29. doi: 10.1056/NEJMoa1209657. N Engl J Med. 2013. PMID: 23883377 Free article. Clinical Trial.
Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry.
Guth S, D'Armini AM, Delcroix M, Nakayama K, Fadel E, Hoole SP, Jenkins DP, Kiely DG, Kim NH, Lang IM, Madani MM, Matsubara H, Ogawa A, Ota-Arakaki JS, Quarck R, Sadushi-Kolici R, Simonneau G, Wiedenroth CB, Yildizeli B, Mayer E, Pepke-Zaba J. Guth S, et al. Among authors: d armini am. ERJ Open Res. 2021 Aug 16;7(3):00850-2020. doi: 10.1183/23120541.00850-2020. eCollection 2021 Jul. ERJ Open Res. 2021. PMID: 34409094 Free PMC article.
Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry.
Pepke-Zaba J, Delcroix M, Lang I, Mayer E, Jansa P, Ambroz D, Treacy C, D'Armini AM, Morsolini M, Snijder R, Bresser P, Torbicki A, Kristensen B, Lewczuk J, Simkova I, Barberà JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Hamid AM, Jaïs X, Simonneau G. Pepke-Zaba J, et al. Among authors: d armini am. Circulation. 2011 Nov 1;124(18):1973-81. doi: 10.1161/CIRCULATIONAHA.110.015008. Epub 2011 Oct 3. Circulation. 2011. PMID: 21969018 Free article.
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
Ghofrani HA, Simonneau G, D'Armini AM, Fedullo P, Howard LS, Jaïs X, Jenkins DP, Jing ZC, Madani MM, Martin N, Mayer E, Papadakis K, Richard D, Kim NH; MERIT study investigators. Ghofrani HA, et al. Among authors: d armini am. Lancet Respir Med. 2017 Oct;5(10):785-794. doi: 10.1016/S2213-2600(17)30305-3. Epub 2017 Sep 11. Lancet Respir Med. 2017. PMID: 28919201 Clinical Trial.
The pathologic basis of recovery.
Narula N, Agozzino M, Gazzoli F, Concardi M, Pagani F, Favalli V, Kodama T, Mazzola A, D'Armini AM, Arbustini E. Narula N, et al. Among authors: d armini am. Heart Fail Clin. 2014 Jan;10(1 Suppl):S63-74. doi: 10.1016/j.hfc.2013.09.001. Heart Fail Clin. 2014. PMID: 24262354 Review.
Chronic thromboembolic pulmonary hypertension.
Piovella F, D'Armini AM, Barone M, Tapson VF. Piovella F, et al. Among authors: d armini am. Semin Thromb Hemost. 2006 Nov;32(8):848-55. doi: 10.1055/s-2006-955467. Semin Thromb Hemost. 2006. PMID: 17171599 Review.
136 results